BioCryst Begins Patient Enrollment in RENEW Proof-of-Concept Trial Evaluating BCX9930…
RESEARCH TRIANGLE PARK, N.C., Feb. 22, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the enrollment of the first patient in the RENEW…